Verona Pharma plc Quarterly Interest Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Verona Pharma plc quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q3 2024.
  • Verona Pharma plc Interest Expense for the quarter ending September 30, 2024 was $9.88M, a 2364% increase year-over-year.
  • Verona Pharma plc Interest Expense for the twelve months ending September 30, 2024 was $13.8M, a 732% increase year-over-year.
  • Verona Pharma plc annual Interest Expense for 2023 was $2.06M, a 295% increase from 2022.
  • Verona Pharma plc annual Interest Expense for 2022 was $521K, a 53.2% increase from 2021.
  • Verona Pharma plc annual Interest Expense for 2021 was $340K, a 871% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.8M $9.88M +$9.48M +2364% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $4.37M $1.76M +$1.02M +137% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.35M $1.59M +$1.29M +441% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.06M $623K +$393K +171% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.66M $401K +$285K +246% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $1.38M $740K +$649K +713% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $730K $293K +$209K +249% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $521K $230K +$145K +171% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $376K $116K +$30K +34.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $346K $91K +$6K +7.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $340K $84K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $340K $85K +$50K +143% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $290K $86K +$86K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $204K $85K +$85K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $119K $84K +$84K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $35K $35K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.